PERBELLINI, Omar
 Distribuzione geografica
Continente #
NA - Nord America 3.410
EU - Europa 3.036
AS - Asia 1.056
SA - Sud America 12
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 1
Totale 7.529
Nazione #
US - Stati Uniti d'America 3.387
GB - Regno Unito 1.289
CN - Cina 939
SE - Svezia 376
DE - Germania 334
FR - Francia 241
IE - Irlanda 233
IT - Italia 215
FI - Finlandia 190
UA - Ucraina 57
BE - Belgio 39
TR - Turchia 25
KR - Corea 24
CA - Canada 23
NL - Olanda 20
VN - Vietnam 15
IR - Iran 14
IN - India 13
AU - Australia 9
ES - Italia 8
BR - Brasile 7
JP - Giappone 6
RU - Federazione Russa 6
NP - Nepal 5
RO - Romania 5
HU - Ungheria 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
GR - Grecia 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
CH - Svizzera 2
CL - Cile 2
HK - Hong Kong 2
IQ - Iraq 2
KZ - Kazakistan 2
SG - Singapore 2
SI - Slovenia 2
AL - Albania 1
AR - Argentina 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
IL - Israele 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NO - Norvegia 1
PE - Perù 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 7.529
Città #
Southend 1.149
Chandler 584
Jacksonville 456
Woodbridge 421
Ann Arbor 397
Dublin 233
Beijing 227
Ashburn 196
New York 136
Wilmington 125
Houston 120
Jinan 94
Lawrence 87
Princeton 87
Nanjing 79
Verona 69
Shenyang 63
Tianjin 49
Helsinki 47
Hebei 45
Falls Church 40
Brussels 37
Haikou 35
Hangzhou 32
Ningbo 32
Nanchang 31
Zhengzhou 29
Changsha 28
Norwalk 24
Boardman 23
Guangzhou 23
Seoul 23
Taiyuan 21
Milan 20
Sindelfingen 20
Taizhou 18
Dearborn 17
Düsseldorf 16
Jiaxing 16
Nürnberg 16
Fuzhou 15
Los Angeles 15
Dong Ket 13
Groningen 12
Lanzhou 12
Manchester 12
Redmond 12
Seattle 12
Redwood City 11
Washington 10
Bologna 9
Lancaster 8
San Mateo 8
Auburn Hills 7
Chicago 7
Toronto 7
Ardabil 6
Augusta 6
Châtenay-Malabry 6
Enterprise 6
Leawood 6
Mestre 6
Paris 6
Cormano 5
Parsa 5
Renton 5
Riva 5
Rome 5
Zanjan 5
Amsterdam 4
Arezzo 4
Costa Mesa 4
Fairfield 4
Monmouth Junction 4
Montreal 4
Pieve di Soligo 4
Qingdao 4
San Francisco 4
São Paulo 4
Verdun 4
Cambridge 3
Changle 3
Clearwater 3
Colorno 3
Edinburgh 3
Hefei 3
Irving 3
Isola della Scala 3
Lissone 3
Mantova 3
Montréal 3
San Jose 3
Sydney 3
Tappahannock 3
Andover 2
Arconate 2
Athens 2
Baltimore 2
Buffalo 2
Castiglione Delle Stiviere 2
Totale 5.505
Nome #
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 353
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 212
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 149
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 142
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 136
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 127
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 123
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 122
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 117
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 110
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 109
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 109
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 108
BCR-signaling profiles associated with prognosis and progression in B-CLL 106
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. 104
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 103
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 101
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 100
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 100
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 98
BCR-signaling profiles associated with prognosis and progression in B-CLL 97
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 97
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells 96
Underdiagnosed systemic mastocytosis: The role of flow cytometry 96
Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia 94
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1 and ICAM-3 94
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 94
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 94
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 93
A quantitative study on the growth variability of tumour cell clones in vitro 91
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 91
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 90
Cross-talks within the innate immune system: the role of neutrophils 88
SIGNALING NETWORK IN T-CELL LYMPHOBLASTIC LEUKEMIA: RESULTS FROM A SINGLE-CELL MULTI-PARAMETRIC PHOSPHO-FLOW CYTOMETRY STUDY 88
Characterization of the cross-talk between human neutrophils and a subset of pro-inflammatory dendritic cells 87
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 86
In Vitro Study Of The Mechanisms Involved In The Bone Marrow Mesenchymal Stromal Cell Modulatory Effect On B Cell Function 85
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 84
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 84
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 83
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 83
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 82
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 81
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 81
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 80
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 80
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 80
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 80
Effects of wheat germ agglutinin on human gastrointestinal epithelium: insights from an experimental model of immune/epithelial cell interaction 79
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 79
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 79
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 78
Human Bone marrow Mesenchymal Stem Cells protect B-cell Acute Lymphoblastic Leukemia from apoptosis in vitro by upregulation of Notch3 and Notch4 on both cell types 78
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 77
Adult T-cell acute lymphoblastic leukemia: prognostic impact of myeloid associated antigens. 76
High incidence of autoimmune complications in 82 patients with non-MALT marginal zone lymphomas. 76
Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia 74
On the potential involvement of CD11d in co-stimulating the production of interferon-{gamma} by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3 74
Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. 74
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 74
The combination of Serum Thymidine Kinase, Beta-2-Microglobulin and soluble CD23 at diagnosis is predictive for progression in B-cell Chronic Lymphocytic Leukemia, independently from ZAP-70 expression 73
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 73
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 73
Notch-3 and Notch-4 signaling rescues from apoptosis Human B-lineage Acute Lymphoblastic Leukemia cells in contact with Human Bone marrow-derived Mesenchymal Stromal Cells 72
null 70
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 70
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 69
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 68
Neutrophil activation and survival are modulated by interaction with NK cells 66
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 66
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 65
Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia 64
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells 64
EPSTEIN-BARR VIRUS DNA LOAD IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF CLINICAL COURSE AND SURVIVAL 64
On the co-purification of 6-sulfo LacNAc(+) dendritic cells (slanDC) with NK cells enriched from human blood. 62
Systemic Reactions After Hymenoptera Sting And Raised Serum Tryptase Strongly Suggest Clonal Mast Cells Disorders 57
null 55
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 54
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 54
Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases 50
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks 43
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders 41
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 40
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 39
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma 37
Multi-parametric phospho-flow cytometry in T-call Acute Lymphoblastic Leukemia 36
IDENTIFICATION AND CHARACTERIZATION OF CANDIDATE MYELOID DERIVED SUP- PRESSOR CELLS IN THE MONONUCLEAR FRACTION OF PERIPHERAL BLOOD SAMPLES FROM PATIENTS AFFECTED BY NON-HODGKIN LYMPHOMA (NHL), HODGKIN LYMPHOMA (HL), AND MULTIPLE MYELOMA (MM) 35
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells 21
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia 17
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 11
Totale 7.615
Categoria #
all - tutte 20.421
article - articoli 10.119
book - libri 0
conference - conferenze 10.302
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019105 0 0 0 0 0 0 0 0 0 0 23 82
2019/2020898 103 19 15 73 85 118 94 73 38 108 80 92
2020/2021887 80 141 49 110 96 95 13 49 33 13 172 36
2021/2022872 86 257 5 83 68 33 20 48 40 23 60 149
2022/20231.667 103 192 134 320 135 403 17 99 206 13 33 12
2023/2024749 51 72 55 76 102 209 60 66 7 47 4 0
Totale 7.615